Mounjaro Quick Pen 2.5 mg - 4 Doses, 1 Pen
Mounjaro is an innovative medication used for the treatment of type 2 diabetes and weight loss in adults. It contains the active ingredient Tirzepatide, a synthetic protein that mimics the effects of natural GIP and GLP-1 hormones.
Active Ingredient
Tirzepatide
Pharmacological Classification
Dual GIP & GLP-1 Receptor Agonist
Mechanism of Action
- Stimulating insulin secretion: Enhances pancreatic beta-cell activity to release insulin, reducing blood sugar levels.
- Reducing glucagon secretion: Lowers hepatic glucose production.
- Delaying gastric emptying: Prolongs satiety and reduces appetite, aiding weight loss.
Medical Uses
- Type 2 Diabetes Treatment:
- Effectively lowers blood sugar levels.
- Improves HbA1c control.
- Reduces diabetes complications.
- Weight Loss Aid:
- Promotes significant weight loss.
- Improves cardiovascular health.
Dosage and Administration
- Administered subcutaneously (abdomen, thigh, or upper arm).
- Recommended dose: One injection per week.
- Missed doses can be taken within 4 days (96 hours); otherwise, skip and resume regular schedule.
Side Effects
1- Serious Side Effects:
- Pancreatitis: Severe abdominal pain radiating to the back.
- Hypoglycemia: Dizziness, sweating, headache, confusion, tremors.
- Severe Allergic Reactions: Swelling, breathing difficulty, rash.
- Kidney Issues: Worsened kidney function due to dehydration.
2- Common Side Effects:
- Nausea, diarrhea, constipation.
- Loss of appetite, stomach pain.
Contraindications
- History of thyroid cancer.
- Type 1 diabetes.
- Pregnancy and breastfeeding.
Storage Instructions
Store refrigerated (2-8°C). Do not freeze.
